No edit summary |
remove {{Lowercase}} - no longer needed |
||
Line 1: | Line 1: | ||
{{orphan|date=January 2010}} |
{{orphan|date=January 2010}} |
||
{{Lowercase}} |
|||
{{Infobox_Company | |
{{Infobox_Company | |
||
company_name = iGuard Inc | |
company_name = iGuard Inc | |
Revision as of 15:05, 13 February 2011
Company type | Private |
---|---|
Founded | 2007 |
Headquarters | Princeton, New Jersey, USA |
Key people | Hugo Stephenson, CEO Elisa Cascade, Head Operations Bob Winslow, Head Medical Information |
Products | Safety research and analysis |
Website | http://www.iguard.org |
The holding company for MediGuard.org is iGuard. The website's aim is to monitor the safety of prescription medicines, over-the-counter medicines and healthcare supplements in over 1,050,000 US patients.[1] The company also rates the safety of different drugs using a standardized ratings scale,[2] and has received critical support from patient advocacy groups concerned by the large number of patients affected by serious, preventable adverse drug reactions.[3]
The company iGuard was founded in 2007 by Hugo Stephenson, MD. It is a subsidiary of Quintiles Transnational, a multinational contract research organization.[4]
Ratings by iGuard
The iGuard site uses a five color rating scale similar to that used by the United States Homeland Security Advisory System to communicate the risk of developing serious side effects. The risk ratings are based on the drug's approved label and research available in major journals. The site publishes general ratings for a wide range of drugs and supplements, and produces personalized ratings that take into account a patient's health profile and interactions between the patient's drugs.
- iGuard Risk Ratings[5]
- High Risk (Red): Requires careful consideration of risk versus benefit with your doctor.
e.g. Adriamycin, Vincristine
- Elevated (Orange): Create a personal risk reduction plan with your doctor
e.g. Prednisone, Warfarin, Insulin
Criticism
Qualitative risk rating systems, such as that used by iGuard, have been criticized for potentially simplifying risk assessment requirements used to inform risk management decisions.[6]
See also
- Boston Collaborative Drug Surveillance Program
- COSTART - Coding Symbols for a Thesaurus of Adverse Reaction Terms
- Pharmacovigilance
- Yellow Card Scheme (UK)
References
- ^ iGuard Patient Numbers www.iGuard.org, accessed 20 January 2009.
- ^ Barriaux, Marianne (2007-10-02). "'Traffic-light' medicine risk website to launch". London: The Guardian. Retrieved 5 May 2010.
- ^ Two Frontrunners for Drug Safety Prevention www.ismp.org, accessed 20 January 2009.
- ^ iGuard Drug Safety Alert is Newest Reason Senior Citizens, Caregivers Must Use Web SeniorJournal.com, 9 October 2007, accessed 19 November 2007.
- ^ iGuard Drug Interactions, Risk Ratings and Safety Alerts
- ^ Cox, Tony; Babayev, Djangir (2005-06-01). "Some Limitations of Qualitative Risk Rating Systems". Risk Analysis. doi:10.1111/j.1539-6924.2005.00615.x?cookieSet=1.
{{cite news}}
: CS1 maint: date and year (link)